Market Tracker

03/03 6:02pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

During the Trading Day
19.72 +0.91 / +4.84%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
19.71 -0.01 / -0.05%
 
Volume: 2.5K

Today’s Trading

Previous close18.81
Today’s open18.90
Day’s range18.76 - 19.85
Volume709,070
Average volume (3 months)329,114
Market cap$494.6M
Dividend yield--
Data as of 4:00pm ET, 03/03/2015

Growth & Valuation

Earnings growth (last year)+7.32%
Earnings growth (this year)-0.79%
Earnings growth (next 5 years)--
Revenue growth (last year)+15.82%
P/E ratioNM
Price/Sales34.19
Price/Book2.65

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...+0.33+2.56%
PGNXProgenics Pharmaceut...+0.13+1.95%
EGRXEagle Pharmaceutical...-0.99-2.63%
VTLVital Therapies Inc+0.14+0.63%
Data as of 4:00pm ET, 03/03/2015

Financials

Last reporting dateMarch 3, 2015
EPS forecast (this quarter)-$0.94
Annual revenue (last year)$11.3M
Annual profit (last year)-$66.7M
Net profit margin-593.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts